Continuing Reviews, Progress Reports, & Final Reports

Continuing Reviews, Progress Reports, & Final Reports

IRB Forms and Applications for Continuing Reviews, Progress Reports, & Final Reports

If approval for continuation is not granted prior to the expiration date of the protocol, all recruitment and subject enrollment must stop. Currently enrolled subjects should continue to receive treatment and follow-up that is in their best interest. Consistent failure to submit timely requests for continuing review is reportable to the FDA, OHRP, and the study sponsor.

Click here to access your study electronically in eIRB

Progress Reports

During Initial review, the IRB Reviewer will determine if Expedited studies can utilize the streamlined Progress Report to renew approval for another review period. The initial IRB approval letter will indicate whether or not your Initial study requires a Progress Report of a Continuing Review to be submitted. 
  • To submit a Continuing Review first open your study in eIRB, and click on the "New Continuing Review" option
  • Then when prompted, select "Progress Report" and attach the Progress Report Form
  • Once complete be sure to have the PI click the "Submit" button on the main page of the Progress Report to submit to IRB for review. 

Progress Report Template (Word)

Progress Report FAQ (Word)

Continuing Review

Expedited studies that are not designated as requiring a Progress Report and all Full Board Review studies require the submission of a Continuing Review prior to the study expiration date. Continuing Reviews are meant for all studies that more than Minimal Risk, involve the collection of Private Health Information, or other considerations including sensitive or vulnerable population considerations as indicated by IRB Reviewers during the initial review. 
  • To submit a Continuing Review first open your study in eIRB, and click on the "New Continuing Review" option
  • Then when prompted, select "Continuing Review" and fill out all of the required sections.
  • Once complete be sure to have the PI click the "Submit" button on the main page of the Continuing Review to submit to IRB for review. 

A study specific Investigator Financial and Other Personal Interest Disclosure Form is required for all research personnel listed on the eIRB application when submitting a Continuing Review Form. Click on the link below to obtain an Investigator Financial and Other Personal Interest Disclosure Form. Please note, all research staff are required to re-sign and date the form every year. 

Final Report

Principal investigators have the responsibility of informing the IRB when a study has been completed.   If a study is completed and not closed, the IRB may not approve a new study until the completed study is closed. A study is considered to be open and active until the investigator has submitted an electronic version of the Final Report to the IRB.  When Final Reports are submitted, an administrative review will be conducted by the IRB staff.  IRB Chair/IRB Director will review the form and report the closure of study to the IRB.

  • To submit a Final Report, open your study in eIRB and click the "New Continuing Review" button. 
  • Then when prompted, select "Final Report" and fill out all of the required sections.
  • Once complete be sure to have the PI click the "Submit" button on the main page of the Final Report to submit to IRB for review. 

Appendices for applications are located here